Iantrek, Inc. is an ophthalmic medical device company developing advanced micro-interventional surgical technologies. The CycloPen™ micro-interventional system targets the suprachoroidal outflow pathway – an established therapeutic target where MIGS micro-stent interventions have demonstrated significant and sustained outflow enhancement with the majority of patients achieving IOP reduction of 20% or more.
Visit website: Iantrekmed.com – What’s next in Micro Interventional eye surgery